Helping You Build Wealth With Honest Research
Since 1996. Read On...

The Best Asset Allocation for Your Equity Portfolio

LAURUS LABS vs ADVANCED ENZYME TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LAURUS LABS ADVANCED ENZYME TECHNOLOGIES LAURUS LABS /
ADVANCED ENZYME TECHNOLOGIES
 
P/E (TTM) x 92.4 19.2 480.7% View Chart
P/BV x 19.1 2.0 939.1% View Chart
Dividend Yield % 0.1 1.8 5.9%  

Financials

 LAURUS LABS    ADVANCED ENZYME TECHNOLOGIES
EQUITY SHARE DATA
    LAURUS LABS
Mar-26
ADVANCED ENZYME TECHNOLOGIES
Mar-26
LAURUS LABS /
ADVANCED ENZYME TECHNOLOGIES
5-Yr Chart
Click to enlarge
High Rs1,141367 311.3%   
Low Rs517252 205.3%   
Sales per share (Unadj.) Rs126.266.6 189.4%  
Earnings per share (Unadj.) Rs16.515.5 106.3%  
Cash flow per share (Unadj.) Rs25.419.1 132.9%  
Dividends per share (Unadj.) Rs2.005.35 37.4%  
Avg Dividend yield %0.21.7 13.9%  
Book value per share (Unadj.) Rs97.7145.0 67.4%  
Shares outstanding (eoy) m539.86111.93 482.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.64.6 141.5%   
Avg P/E ratio x50.319.9 252.3%  
P/CF ratio (eoy) x32.716.2 201.7%  
Price / Book Value ratio x8.52.1 397.8%  
Dividend payout %12.134.5 35.2%   
Avg Mkt Cap Rs m447,52834,611 1,293.0%   
No. of employees `000NANA-   
Total wages/salary Rs m8,1541,623 502.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m68,1297,458 913.6%  
Other income Rs m550357 153.7%   
Total revenues Rs m68,6797,815 878.8%   
Gross profit Rs m17,7772,406 738.8%  
Depreciation Rs m4,801401 1,197.3%   
Interest Rs m1,70737 4,572.3%   
Profit before tax Rs m11,8192,325 508.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,920589 495.6%   
Profit after tax Rs m8,8991,736 512.6%  
Gross profit margin %26.132.3 80.9%  
Effective tax rate %24.725.3 97.5%   
Net profit margin %13.123.3 56.1%  
BALANCE SHEET DATA
Current assets Rs m48,29210,436 462.8%   
Current liabilities Rs m36,3541,067 3,406.4%   
Net working cap to sales %17.5125.6 13.9%  
Current ratio x1.39.8 13.6%  
Inventory Days Days29309 9.3%  
Debtors Days Days1271 16.3%  
Net fixed assets Rs m56,8207,903 719.0%   
Share capital Rs m1,080224 482.3%   
"Free" reserves Rs m51,67116,004 322.9%   
Net worth Rs m52,75116,228 325.1%   
Long term debt Rs m6,11379 7,751.2%   
Total assets Rs m105,11218,339 573.2%  
Interest coverage x7.963.3 12.5%   
Debt to equity ratio x0.10 2,384.5%  
Sales to assets ratio x0.60.4 159.4%   
Return on assets %10.19.7 104.3%  
Return on equity %16.910.7 157.7%  
Return on capital %23.014.5 158.6%  
Exports to sales %019.2 0.0%   
Imports to sales %28.413.0 218.1%   
Exports (fob) Rs mNA1,433 0.0%   
Imports (cif) Rs m19,330970 1,992.4%   
Fx inflow Rs m43,4701,433 3,033.9%   
Fx outflow Rs m19,330970 1,992.4%   
Net fx Rs m24,140463 5,218.2%   
CASH FLOW
From Operations Rs m16,2351,568 1,035.6%  
From Investments Rs m-10,887-741 1,468.6%  
From Financial Activity Rs m-5,247-704 745.7%  
Net Cashflow Rs m131145 90.3%  

Share Holding

Indian Promoters % 27.5 2.0 1,408.7%  
Foreign collaborators % 0.0 41.3 -  
Indian inst/Mut Fund % 41.7 31.5 132.6%  
FIIs % 28.0 26.7 104.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.5 56.8 127.8%  
Shareholders   291,653 63,599 458.6%  
Pledged promoter(s) holding % 2.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LAURUS LABS With:   CIPLA    DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on LAURUS LABS vs ADVANCED ENZYME TECHNOLOGIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

LAURUS LABS vs ADVANCED ENZYME TECHNOLOGIES Share Price Performance

Period LAURUS LABS ADVANCED ENZYME TECHNOLOGIES S&P BSE HEALTHCARE
1-Day 0.59% -9.08% -0.06%
1-Month 21.31% -10.54% 2.53%
1-Year 124.47% -1.78% 17.33%
3-Year CAGR 67.35% -3.90% 21.83%
5-Year CAGR 21.42% -5.72% 14.20%

* Compound Annual Growth Rate

Here are more details on the LAURUS LABS share price and the ADVANCED ENZYME TECHNOLOGIES share price.

Moving on to shareholding structures...

The promoters of LAURUS LABS hold a 27.5% stake in the company. In case of ADVANCED ENZYME TECHNOLOGIES the stake stands at 43.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LAURUS LABS and the shareholding pattern of ADVANCED ENZYME TECHNOLOGIES.

Finally, a word on dividends...

In the most recent financial year, LAURUS LABS paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 12.1%.

ADVANCED ENZYME TECHNOLOGIES paid Rs 5.4, and its dividend payout ratio stood at 34.5%.

You may visit here to review the dividend history of LAURUS LABS , and the dividend history of ADVANCED ENZYME TECHNOLOGIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends Flat | Nifty Above 24,550 | Hitachi Energy Up 10%(Closing)

Although the benchmark indices opened higher, they traded positive throughout the session and ultimately closed flat.